Specialist in drug discovery science, molecular biology, and immunology. Graduated from the Faculty of Pharmaceutical Sciences at the University of Tokyo and earned a Ph.D. in Pharmaceutical Sciences from the University of Tokyo Graduate School. He has held research positions at Albert Einstein College of Medicine, Memorial Sloan Kettering Cancer Center (New York, USA), and RIKEN (Japan). Since 1999, he has been a Professor in the Department of Biotechnology, Faculty of Engineering, Tokyo University of Science. Since his tumor virus research at Memorial Sloan Kettering, he has consistently focused on identifying therapeutic target molecules, developing antibody production methods, and advancing antibody-based drug development. He has produced over 700 research antibodies and holds world-leading achievements in diagnostic and therapeutic antibody development.
Fields of Expertise:
Regenerative Medicine, Drug Discovery Science, Molecular Biology, Immunology
Professional Affiliations:
Tokyo Metropolitan Bio-Genome Venture Network
Genome Drug Discovery Medical Forum
Genome Drug Discovery Forum
DNA Engineering Society
International Journal of Immunology and Immunotherapy
International Journal of Cancer & Cellular Biology Research
International Journal of Biomedical Engineering and Science
Austin Journal of Cancer and Clinical Research
Publications:
- What Will Genome Analysis Bring? (2002)
- Professor Shigematsu’s Guide to Scholarship (2006)
- Introduction to Post-Genome Molecular Biology (2007)
- Personalized Medicine (2011), Chapter 12: “Development Strategy of Antibody Therapeutics and Personalized Medicine”
…among many others
Career History:
Ph.D. in Pharmaceutical Sciences, University of Tokyo
Former Research Fellow, Memorial Sloan Kettering Cancer Center
Since 1999: Professor, Tokyo University of Science, Department of Biotechnology
Founder and Director, Biomatrix Research Institute
Since 2002: Head of Structural Genomics Division, Genome Drug Discovery Center, Tokyo University of Science
